We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

11 hedge funds and large institutions have $10M invested in Arcadia Biosciences in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,673% more capital invested

Capital invested by funds: $210K → $10M (+$9.81M)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

38% more funds holding

Funds holding: 8 → 11 (+3)

0.4% more ownership

Funds ownership: 0% → 0.41% (+0.4%)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$1.69M
2
SM
Sabby Management
Florida
+$1.69M
3
LRPA
L. Roy Papp & Associates
Arizona
+$209K
4
Renaissance Technologies
Renaissance Technologies
New York
+$187K
5
Squarepoint
Squarepoint
New York
+$186K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$28K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$14K
3
Goldman Sachs
Goldman Sachs
New York
-$6K
4
Northern Trust
Northern Trust
Illinois
-$4K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$4.14M +$1.69M +3,763 New
SM
2
Sabby Management
Florida
$3.61M +$1.69M +3,763 New
Renaissance Technologies
3
Renaissance Technologies
New York
$1.06M +$187K +416 +60%
LRPA
4
L. Roy Papp & Associates
Arizona
$445K +$209K +464 New
Squarepoint
5
Squarepoint
New York
$399K +$186K +415 New
Bank of Montreal
6
Bank of Montreal
Ontario, Canada
$240K +$112K +250 New
Wells Fargo
7
Wells Fargo
California
$70K +$32.8K +73 New
UBS Group
8
UBS Group
Switzerland
$28K +$2.25K +5 +21%
Barclays
9
Barclays
United Kingdom
$24K +$11.2K +25 New
BlackRock
10
BlackRock
New York
$5K – – –
SWM
11
SeaCrest Wealth Management
New York
$1K – – –
VF
12
Virtu Financial
New York
– -$28K -128 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$14K -66 Closed
Goldman Sachs
14
Goldman Sachs
New York
– -$6K -26 Closed
Northern Trust
15
Northern Trust
Illinois
– -$4K -20 Closed
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$3 – –

RKDA Hedge Fund Activity: Q1 2018 in Review

11 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2018, worth a combined $10M — up 4,673% from $210K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new RKDA positions and 4 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $1.69M. The largest seller was Virtu Financial, exiting entirely with an estimated $28K sold.

  • 11 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2018, up from 8 in Q4 2017.
  • Funds reported $10M of Arcadia Biosciences stock for Q1 2018, up 4,673% quarter-over-quarter.
  • 7 funds opened new Arcadia Biosciences positions in Q1 2018 and 4 closed out, a net change of +3 holders.
  • The largest Arcadia Biosciences buyer in Q1 2018 was Hudson Bay Capital Management, an estimated $1.69M added.
  • The largest Arcadia Biosciences seller in Q1 2018 was Virtu Financial, an estimated $28K sold.

Based on aggregated 13F filings for Q1 2018.